Melanoma Bridge 2023

 

Melanoma Bridge 2023
Avatar

New Interesting Targets From Recent Melanoma Research

By Melanoma Bridge 2023 FEATURING Omid Hamid
By Melanoma Bridge 2023 FEATURING Omid Hamid
0 views
December 27, 2023
Comments 0
Login to view comments. Click here to Login
Videos
15:46
Melanoma Bridge 2023

Treatment of Symptomatic Brain Metastases in Melanoma: Combination o…

Feat. H. Tawbi
09:58
Melanoma Bridge 2023

Drug Development in Melanoma: Why Do We Need Novel Trial Designs?

Feat. M. Khasraw
14:00
Melanoma Bridge 2023

Is SLN Biopsy No Longer Necessary for Patients With High-Risk Primar…

Feat. J. Luke
12:22
Melanoma Bridge 2023

Drug Development in Melanoma: Phase I/II/III vs. Novel Designs

Feat. I. Puzanov
20:32
Melanoma Bridge 2023

Targeted Therapy in BRAF-Mutated Metastatic Melanoma

Feat. R. Dummer
19:12
Melanoma Bridge 2023

Adjuvant IO in Stage II Melanoma

Feat. A. Arance
15:06
Melanoma Bridge 2023

Is Seeing Believing With Immunotherapy for Melanoma?

Feat. M. Postow
05:37
Melanoma Bridge 2023

COLUMBUS 7-Year Update: Encorafenib + Binimetinib vs. Vemurafenib or…

Feat. R. Dummer
17:18
Melanoma Bridge 2023

Breaking Boundaries With New Era of Therapeutic Cancer Vaccines Buil…

Feat. M. Postow
14:41
Melanoma Bridge 2023

Engineered T-Cells

Feat. O. Michielin
11:18
Melanoma Bridge 2023

Biomarkers Directing Melanoma Immunotherapy: Useful or Not Useful?

Feat. A. Eggermont
17:39
Melanoma Bridge 2023

Major Emerging Paradigm Shifts That Will Change Melanoma Management …

Feat. A. Eggermont
15:07
Melanoma Bridge 2023

Regional Therapy in the Management of Advanced Uveal Melanoma

Feat. R. Carvajal
16:31
Melanoma Bridge 2023

Novel Adjuvant and Neoadjuvant Approaches in Melanoma: Which Are Poi…

Feat. J. Mehnert
13:40
Melanoma Bridge 2023

Treating PD-1 Refractory Melanoma With TIL Therapy vs. Nivo+Ipi: Pro…

Feat. A. Betof Warner
14:36
Melanoma Bridge 2023

Treating PD-1 Refractory Melanoma With TIL Therapy vs. Nivo+Ipi: Pro…

Feat. J. Smithy
13:31
Melanoma Bridge 2023

What Is the Best Initial Treatment for Unresectable Mucosal Melanoma…

Feat. J. Luke
15:39
Melanoma Bridge 2023

Putting It All Together: Practical Considerations for Monday Clinic …

Feat. S. S. Agarwala
14:12
Melanoma Bridge 2023

Molecular Imaging vs. Radiomics: Pro-Imaging

Feat. S. Krebs
11:56
Melanoma Bridge 2023

Adjuvant Therapy in Stage II Melanoma: Tools to Balance the Choice

Feat. P. Ascierto
14:42
Melanoma Bridge 2023

Expectations, Concerns, and The Unknown: A SITC Perspective on Survi…

Feat. M. Ernstoff
17:29
Melanoma Bridge 2023

Debate: Is SLN Biopsy No Longer Necessary for Pts With High-Risk Pri…

Feat. J. Gershenwald
19:11
Melanoma Bridge 2023

Targeted Therapy in Melanoma: Sequencing and Beyond

Feat. P. Ascierto
15:38
Melanoma Bridge 2023

New Interesting Targets From Recent Melanoma Research

Feat. O. Hamid